Libido and Sexual Health in Menopause
Changes in libido and sexual function during the menopause transition have biological, contextual, and relational components. Here is what the evidence supports — including the careful framing on testosterone — and how to find a clinician comfortable with the conversation.
By The HRT Index Editorial Team · Published 2026-05-15 · Last reviewed by editors: 2026-05-26
Editorial research — not medically reviewed by a clinician.
No active affiliate links on this page as of 2026-05-26.
This article is educational and is not medical advice. Consult your clinician before starting, stopping, or changing hormone therapy. Individual responses to HRT vary; the right hormones, doses, and delivery methods for you depend on your medical history and clinical context.
Your situation changes the answer
Find My HRT Path
The right online HRT provider isn't the same for every woman. It depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state — and some situations belong with an in-person clinician first. Because a general answer can't resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider, and to flag when online care isn't the right starting point, before your first consult.
- What it asks: your symptoms, age and uterus status, medication route preference, insurance or cash-pay situation, and state
- What you get: a personalized shortlist of online HRT providers matched to your situation, with verified pricing, plus a clear flag when online care isn't the right starting point
- Cost: free · about 60 seconds · no signup
What is biological, what is contextual
Several distinct things change during the menopause transition, and they get conflated in everyday conversation. Vaginal dryness and painful intercourse are local tissue changes driven by declining estradiol and are highly treatable with low-dose vaginal estrogen. Reduced arousal and reduced orgasm intensity are partly local tissue changes and partly central. Reduced spontaneous desire is more complicated — it has hormonal components (estradiol and testosterone both contribute), it has contextual components (sleep, stress, the cumulative effect of a long-term relationship, medications including SSRIs), and it has relational components.
Estrogen and progesterone
Systemic HRT often improves the local tissue picture and the contextual picture indirectly (better sleep, fewer hot flashes, better mood). For many women, that is enough to materially change the sexual-health picture without any specific intervention beyond standard HRT. For patients whose primary issue is the local tissue change, vaginal estrogen alone is often sufficient.
Testosterone in women: the honest picture
Testosterone is not FDA-approved for women in the United States. The strongest evidence-based use is carefully monitored, off-label treatment of hypoactive sexual desire disorder (HSDD) in selected postmenopausal women after other contributors are assessed. The 2019 Global Consensus Position Statement on testosterone therapy in women concluded that HSDD is the only evidence-based indication — it should not be promoted as a general treatment for energy, mood, weight, anti-aging, or nonspecific “hormone optimization.”
Low libido can also come from vaginal pain, relationship stress, depression, anxiety, sleep disruption, medications such as SSRIs, alcohol use, body-image distress, trauma history, thyroid disease, or other medical conditions. A good libido evaluation should not jump straight to testosterone.
Where to start the conversation
Most of the providers we cover have a stated posture on female testosterone. Midi and Alloy prescribe it in defined clinical contexts. Winona does notprescribe testosterone — it offers DHEA, a hormone precursor, instead; see our full breakdown of what Winona prescribes and why. Hers and Pandia do not currently include testosterone in their standard formulary. The patient who specifically wants this conversation should look for a practice whose materials are explicit about it; see the provider comparison.
What we will not promise
A pill, patch, or cream cannot resolve a contextual or relational driver of low libido. The best treatment outcomes in this area tend to combine a careful clinical approach to the biology with attention to sleep, stress, relationship, and — where useful — a referral to a clinician trained in sexual health specifically. We will not promise a specific timeframe or a specific improvement; what we can do is help you find a clinician who treats the question with the seriousness it deserves.
Sources used for this guide
This guide was editorially checked against current materials from The Menopause Society, FDA labeling or safety communications, and relevant peer-reviewed literature on sexual function, HSDD, and testosterone use in menopausal women.
Your situation changes the answer
Find My HRT Path
The right online HRT provider isn't the same for every woman. It depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state — and some situations belong with an in-person clinician first. Because a general answer can't resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider, and to flag when online care isn't the right starting point, before your first consult.
Find My HRT Path →